Invention Grant
- Patent Title: Heterocyclic compounds useful as PDK1 inhibitors
- Patent Title (中): 用作PDK1抑制剂的杂环化合物
-
Application No.: US13499835Application Date: 2010-10-05
-
Publication No.: US09546165B2Publication Date: 2017-01-17
- Inventor: Joseph Arndt , Timothy Chan , Kevin Guckian , Gnanasambandam Kumaravel , Wen-Cherng Lee , Edward Yin-Shiang Lin , Daniel Scott , Lihong Sun , Jermaine Thomas , Kurt van Vloten , Deping Wang , Lei Zhang , Daniel Erlanson
- Applicant: Joseph Arndt , Timothy Chan , Kevin Guckian , Gnanasambandam Kumaravel , Wen-Cherng Lee , Edward Yin-Shiang Lin , Daniel Scott , Lihong Sun , Jermaine Thomas , Kurt van Vloten , Deping Wang , Lei Zhang , Daniel Erlanson
- Applicant Address: US CA South San Francisco US MA Cambridge
- Assignee: Sunesis Pharmaceuticals, Inc.,Millennium Pharmaceuticals, Inc.
- Current Assignee: Sunesis Pharmaceuticals, Inc.,Millennium Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco US MA Cambridge
- Agency: Choate, Hall & Stewart LLP
- International Application: PCT/US2010/051517 WO 20101005
- International Announcement: WO2011/044157 WO 20110414
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D487/04 ; C07D239/94 ; C07D241/26 ; C07D213/82 ; C07D213/85 ; C07D401/12 ; C07D401/14 ; C07D403/12 ; C07D403/14 ; C07D405/14 ; C07D409/04 ; C07D409/14 ; C07D417/14 ; C07D473/34 ; C07D491/052 ; C07D519/00 ; C07D241/28 ; C07D498/04
Abstract:
The present invention provides compounds useful as inhibitors of PDK1. The present invention also provides compositions thereof, and methods of treating PDK1-mediated diseases.
Public/Granted literature
- US20120208819A1 HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS Public/Granted day:2012-08-16
Information query
